Bmi![]() Bmi articles1. Prostate Cancer :: Obesity and overweight linked to higher prostate cancer mortalityMen who are overweight or obese when diagnosed with prostate cancer are at greater risk of death after treatment, according to a new study in the December 15, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society. The study, by Dr. Jason Efstathiou from Massachusetts General Hospital in Boston and colleagues, found that a greater body mass index (BMI) at the time of cancer diagnosis was an independent risk factor for prostate cancer-related death. 2. Education :: CBSE accepts on-line application for pre-med entrance exam-2008, India The Indian education authority CBSE began accepting on-line applications for the All India Pre-medical/Pre-dental entrance examination, 2008. Aspiring students can submit their applications on-line on the website of the Central Board of Secondary Education, a CBSE official said. 3. Health :: Conversation on health ends with record participation The final numbers are in. The Conversation on Health has ended, with over 12,000 submissions and thousands more people taking part in public forums, providing their ideas on the future of the health system. 4. Multiple Sclerosis :: Accentia announces investigational new drug application for Revimmune for refractory MS Accentia Biopharmaceuticals announces that it met with the Food and Drug Administration (FDA) on September_26, 2007 for a scheduled pre-Investigational New Drug (pre-IND) meeting on Revimmune™. The FDA has indicated its support for Accentia to submit an IND for a pivotal Phase 3 randomized controlled, multi-center clinical trial of Revimmune, the company’s potential therapeutic for refractory, relapsing-remitting Multiple Sclerosis (MS). 5. Cancer :: Decrease in the use of radiotherapy procedures for the treatment of cancer in hospitals The study is based on data of patients, treated in any of the 10 Andalusian public hospitals for one year, who were submitted to radiotherapy procedures for the treatment of tumours in the breast, lung, head and neck, cervix and endometrium. |